Drug-labels.com

Mar-Losartan: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
25 mg, 50 mg, 100 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mar-Losartan

ABOUT THIS MEDICATION

What the medication is used for:

Adults

  • lowering high blood pressure;
  • providing kidney protection by delaying the

    worsening of kidney disease in type 2 diabetic patients with protein in the urine (proteinuria) and high blood pressure.

Children (6-16 years)

  • lowering high blood pressure.

What it does:

MAR-LOSARTAN belongs to a class of drugs known as angiotensin II receptor antagonists. Its action is to lower blood pressure by relaxing the blood vessels.

When it should not be used:

Do not take MAR-LOSARTAN if you are allergic to losartan potassium or any of the nonmedicinal ingredients (see What the important nonmedicinal ingredients are).

Do not take MAR-LOSARTAN if you are already taking a blood pressure lowering medicine that contains aliskiren (such as Rasilez) and you have diabetes or kidney disease.

What the medicinal ingredient is:

Losartan potassium

What the important nonmedicinal ingredients are: MAR-LOSARTAN contains the following nonmedicinal ingredients: Microcrystalline cellulose, Starch pregelatinized, Colloidal silicon dioxide, Lactose monohydrate, Magnesium Stearate, Hypromellose 5 cps, Hydroxypropyl Cellulose, Titanium dioxide and water.

MAR-LOSARTAN 25 mg, 50 mg and 100 mg tablets

contain the following amounts of potassium: 2.12 mg (<1 mmol), 4.24 mg (<1 mmol), and 8.48 mg (<1 mmol) respectively.

Although MAR-LOSARTAN tablets contain potassium, this amount is too small to replace potassium supplements. If your doctor has prescribed potassium supplements, continue to follow his advice.

What dosage forms it comes in:

Tablets of 25 mg, 50 mg and 100 mg.

WARNINGS AND PRECAUSTIONS

Serious Warnings and Precautions MAR-LOSARTAN should not be used during pregnancy. If you discover that you are pregnant while taking MAR-LOSARTAN, stop the medication and please contact your physician.

BEFORE you use MAR-LOSARTAN talk to your doctor or pharmacist if:

  • you perform tasks which may require special attention (for example, driving an automobile or operating dangerous machinery). Almost all patients can, but you should not perform these tasks, until you know how you respond to your medicine.

  • you have or have had any medical problems, and about any allergies.
  • you are taking potassium supplements, potassium-sparing agents or salts substitutes containing potassium.
  • you are taking a medicine that contains aliskiren, such as Rasilez, used to lower high blood pressure. The combination with MAR-LOSARTAN is not recommended.
  • you are taking an angiotensin-converting-enzyme inhibitor (ACEI).
  • you are taking any medication including non-prescription and herbal products.
  • you have recently suffered from excess vomiting or diarrhea.
  • you have liver, kidney, heart or heart valve disease.

    you are allergic to this drug or to any ingredient in the formulation .

You are pregnant, breast-feeding or thinking of becoming pregnant?

Taking MAR-LOSARTAN during pregnancy can cause injury and even death to your baby. This medicine should not be used during pregnancy. If you are planning to become pregnant while taking MAR-LOSARTAN, contact immediately your physician.

It is possible that MAR-LOSARTAN passes into breast milk. You should discuss with your physician about taking MAR-LOSARTAN while breastfeeding.

Remember that your doctor has prescribed this medicine only for you. Never give it to anyone else.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interaction with other drugs is possible. Therefore, do not take any other medicines unless you have discussed the matter with your doctor or your pharmacist. It is important to tell your doctor if you are taking:

  • Lithium salts
  • Digitalis
  • Warfarin
  • Rifampin
  • Erythromycin
  • Fluconazole
  • Phenobarbital
  • Cimetidine
  • Non-steroidal anti-inflammatory drug (such as

    indomethacin)

  • Diuretics (water pills) - patients on diuretics may

    occasionally experience an excessive reduction of blood pressure after initiation of therapy with MAR-LOSARTAN.

  • Potassium supplements or salt substitutes containing

    potassium.

  • Other blood pressure medicines

Certain medicines tend to increase your blood pressure, for example, some, but not all, non-prescription preparations for appetite control, asthma, colds, coughs, hay fever and sinus problems.

PROPER USE OF THIS MEDICATION

U

sual dose:

•

Take MAR-LOSARTAN every day exactly as your

doctor has instructed. It is important to continue taking MAR-LOSARTAN for as long as your doctor prescribes it in order to maintain smooth control of your blood pressure.

  • MAR-LOSARTAN may be taken with or without food, but it should be taken consistently with respect to food intake, at about the same time every day.

Hypertension

  • For adult patients, the usual starting dose is 50 mg once

    daily. The usual dose range is 50 to 100 mg once daily.

  • Most older patients require the same dose as younger

    patients, since MAR-LOSARTAN works equally well and is equally well tolerated by most older and younger adult patients.

  • For pediatric patients (6-16 years of age) who can

    swallow tablets, the recommended dose is 25 mg once daily in patients between 20 and 49 kg. The dose can be increased to a maximum of 50 mg once daily. In patients greater or equal to 50 kg, the starting dose is 50 mg once daily. The dose can be increased to a maximum of 100 mg once daily.

Type 2 diabetes patients with proteinuria and hypertension

  • For adults, the usual starting dose is 50 mg once daily. The dose may be increased to 100 mg once daily.

Overdose:

In case of an overdose, contact a physician, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed dose:

Try to take MAR-LOSARTAN daily, as prescribed. However, if you miss a dose, do not take an extra dose. Just resume your usual schedule.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Any medicine may have unintended or undesirable effects, so-called side effects. Some patients may experience fatigue, hives, taste alteration or vomiting. Tell your doctor or pharmacist promptly about these or any other unusual symptoms.

Some patients, especially those with type 2 diabetes with protein in the urine, may also develop increased levels of potassium in their blood.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / EffectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency medical attention

Only if

severe

In all cases

Allergic reactions involving

swelling of the face, lips, throat and/ or tongue which may cause difficulty in

breathing or

swallowing

✓
Rash✓
Light headedness/ Dizziness✓
Low blood pressure✓
Muscle pain✓

Muscle tenderness or weakness or dark/brown urine (signs of

rhabdomyolysis*)

✓

* Rhabdomyolysis is a muscle-wasting disease which in rare cases can lead to kidney failure.

This is not a complete list of side effects. For any unexpected effects while taking MAR-LOSARTAN, contact your doctor or pharmacist.

HOW TO STORE IT

Store at room temperature (15°C - 30°C). Keep container tightly closed. Protect from light.

Keep all medicines out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at

www.healthcanada.gc.ca/medeffect

NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program or Merck do not provide medical Advice

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals is available by contacting the sponsor, Marcan Pharmaceuticals Inc.

Date of Preparation: March 27, 2014.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02422468

Revision date stated in the text: March 27, 2014

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mar-Losartan

Rx or OTC
Prescription (Rx)?
DIN 02422468, 02422476, 02422484
Schedule(s) PRESCRIPTION
Active ingredient(s) Losartan potassium
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA01 Losartan
Company MARCAN PHARMACEUTICALS INC
Current status Cancelled Pre Market
Current status date May 13, 2021
Strengths and forms
DIN Strength Dosage form(s) Current status
02422468 25 MG Tablet Cancelled Pre Market May 13, 2021
02422476 50 MG Tablet Cancelled Pre Market May 13, 2021
02422484 100 MG Tablet Cancelled Pre Market May 13, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.